OpenVSafe by OpenVAERS
Search V-safe

DLE-96719-24864

3 vaccinations 1 coded response 13 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
442 / OH
Registered
2021-11-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
9NY-20208-96658 Child or adolescent in my care · Female · 2021-11-20
8YX-18012-72516 Child or adolescent in my care · Female · 2022-02-18

Timeline

  1. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-20
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-19
    Dose 3 — Pfizer-BioNTech
  4. 2021-11-20
    Registered in v-safe
  5. 2021-11-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-11-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-11-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-11-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-11-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-11-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-11-26
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2021-12-03
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-12-10
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-12-17
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-12-24
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-12-31
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-18
    Survey response — 3 months, dose 3
    MedDRA: Pre-eclampsia, Right ventricular failure — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Post partum preeclampsia and right sided heart failure
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-02-18
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  19. 2022-02-22

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech No
22021-04-20Pfizer-BioNTech No
32021-11-19Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — 3 months, dose 3

2022-02-18

Symptoms: Post partum preeclampsia and right sided heart failure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPre-eclampsia · · ✓
SDRight ventricular failure · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…